Article Details

Replimune to Present New Biomarker & Pre-clinical Data for Lead Oncolytic Immunotherapy ...

Retrieved on: 2021-04-12 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

Replimune to Present New Biomarker & Pre-clinical Data for Lead Oncolytic Immunotherapy .... View article details on hiswai:

Excerpt

Data confirms potent anti-tumor activity & activation of robust systemic immune responses by RP1 and RP2. Increased infiltration of CD8+ T cells and ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up